Deutsch English Français

Contact

EP1588707

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1588707

EP1588707 - STABLE SOLID MEDICINAL COMPOSITION FOR ORAL ADMINISTRATION OF RAMOSETRON [Right-click to bookmark this link]
Former [2005/43]	STABLE SOLID MEDICINAL COMPOSITION FOR ORAL ADMINISTRATION
	[2008/22]
Status	No opposition filed within time limit Status updated on 20.11.2009 Database last updated on 17.05.2024
Most recent event Tooltip	07.10.2011	Lapse of the patent in a contracting state New state(s): CY	published on 09.11.2011 [2011/45]
Applicant(s)	For all designated states Astellas Pharma Inc. 3-11, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo 103-8411 / JP
	[2009/03]
Former [2005/47]	For all designated states Astellas Pharma Inc. 3-11, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo 103-8411 / JP
Former [2005/43]	For all designated states YAMANOUCHI PHARMACEUTICAL CO. LTD. No. 3-11 Nihonbashi-Honcho, 2-chome Chuo-ku Tokyo 103-8411 / JP
Inventor(s)	01 / SUGIHARA, A c/o Astellas Pharma Inc. 180, Ozumi Yaizu-shi, Shizuoka 425-0072 / JP
	02 / MASAKI, K. c/o Astellas Pharma Inc. 180, Ozumi Yaizu-shi, Shizuoka 425-0072 / JP
	03 / YASUJI, T. c/o Astellas Pharma Inc. 180, Ozumi Yaizu-shi, Shizuoka 425-0072 / JP
	04 / NISHIDA, A. c/o Astellas Pharma Inc. 17-1, Hasune 3-chome, Itabashi-ku Tokyo 174-8612 / JP
	05 / NIWA, A. c/o Astellas Pharma Inc. 17-1, Hasune 3-chome, Itabashi-ku Tokyo 174-8612 / JP
	06 / ATSUTA, Y. c/o Astellas Pharma Inc. 17-1, Hasune 3-chome, Itabashi-ku Tokyo 174-8612 / JP
	[2009/01]
Former [2006/04]	01 / SUGIHARA, A. c/o Yamanouchi Pharmaceutical Co.Ltd. 180, Ozumi Yaizu-shi, Shizuoka 425-0072 / JP
	02 / MASAKI, K. c/oYamanouchi Pharmaceutical Co.Ltd. 180, Ozumi Yaizu-shi, Shizuoka 425-0072 / JP
	03 / YASUJI, T. c/o Yamanouchi Pharmaceutical Co.Ltd 180, Ozumi Yaizu-shi, Shizuoka 425-0072 / JP
	04 / NISHIDA, A. c/o Yamanouchi Pharmaceutical Co.Ltd 17-1, Hasune 3-chome, Itabashi-ku Tokyo 174-8612 / JP
	05 / NIWA, A. c/o Yamanouchi Pharmaceutical Co.Ltd 17-1, Hasune 3-chome, Itabashi-ku Tokyo 174-8612 / JP
	06 / ATSUTA, Y. c/o Yamanouchi Pharmaceutical Co.Ltd 17-1, Hasune 3-chome, Itabashi-ku Tokyo 174-8612 / JP
Former [2005/43]	01 / SUGIHARA, Akio, c/o Yamanouchi Pharmaceutical Co. 180, Ozumi Yaizu-shi, Shizuoka 425-0072 / JP
	02 / MASAKI, Katsuhiro, Yamanouchi Pharmaceutical Co. 180, Ozumi Yaizu-shi, Shizuoka 425-0072 / JP
	03 / YASUJI, Takehiko, Yamanouchi Pharmaceutical Co. 180, Ozumi Yaizu-shi, Shizuoka 425-0072 / JP
	04 / NISHIDA, Akito, 2c/o Yamanouchi Pharmaceutical Co. 17-1, Hasune 3-chome, Itabashi-ku Tokyo 174-8612 / JP
	05 / NIWA, Akira, c/o Yamanouchi Pharmaceutical Co. 17-1, Hasune 3-chome, Itabashi-ku Tokyo 174-8612 / JP
	06 / ATSUTA, Yutaka, c/o Yamanouchi Pharmaceutical Co. 17-1, Hasune 3-chome, Itabashi-ku Tokyo 174-8612 / JP
Representative(s)	Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastrasse 30 81925 München / DE
	[N/P]
Former [2005/43]	HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastrasse 4 81925 München / DE
Application number, filing date	04706797.0	30.01.2004
	[2005/43]
	WO2004JP00896
Priority number, date	JP20030023500	31.01.2003 Original published format: JP 2003023500
	[2005/43]
Filing language	JA
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2004066998
	Date:	12.08.2004
	Language:	EN
	[2004/33]
	Type:	A1 Application with search report
	No.:	EP1588707
	Date:	26.10.2005
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 12.08.2004 takes the place of the publication of the European patent application.
	[2005/43]
	Type:	B1 Patent specification
	No.:	EP1588707
	Date:	14.01.2009
	Language:	EN
	[2009/03]
Search report(s)	International search report - published on:	JP	12.08.2004
	(Supplementary) European search report - dispatched on:	EP	30.01.2006
Classification	IPC:	A61K31/4184, A61K9/14, A61K9/20, A61K47/02, A61K47/12, A61K47/14, A61K47/18, A61K47/22, A61K47/30, A61K47/38, A61P1/00, A61P25/00, A61P43/00, C07D403/06	[2005/43]
	CPC:	A61K31/19 (EP,US); A61K31/4184 (EP,KR,US); A61K47/12 (US); A61K47/14 (US); A61K47/32 (US); A61K9/0056 (EP); (+) A61K9/14 (KR); A61K9/1623 (EP); A61K9/20 (KR); A61K9/2018 (EP); A61P1/00 (EP); A61P1/12 (EP); A61P25/00 (EP); A61P43/00 (EP); C07D213/61 (EP,US) (-)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/43]
Extension states	AL	Not yet paid
	LT	Not yet paid
	LV	Not yet paid
	MK	Not yet paid
Title	German:	STABILE FESTE MEDIZINISCHE ZUSAMMENSETZUNG FÜR DIE ORALE VERABREICHUNG VON RAMOSETRON	[2008/22]
	English:	STABLE SOLID MEDICINAL COMPOSITION FOR ORAL ADMINISTRATION OF RAMOSETRON	[2008/22]
	French:	COMPOSITION MEDICINALE SOLIDE, STABLE, D'ADMINISTRATION PAR VOIE ORALE DE RAMOSETRON	[2008/22]
	Former [2005/43]	STABILE FESTE MEDIZINISCHE ZUSAMMENSETZUNGFÜR DIE ORALE VERABREICHUNG
	Former [2005/43]	STABLE SOLID MEDICINAL COMPOSITION FOR ORAL ADMINISTRATION
	Former [2005/43]	COMPOSITION MEDICINALE SOLIDE, STABLE, D'ADMINISTRATION PAR VOIE ORALE
Entry into regional phase	14.07.2005	Translation filed
	14.07.2005	National basic fee paid
	14.07.2005	Search fee paid
	14.07.2005	Designation fee(s) paid
	14.07.2005	Examination fee paid
Examination procedure	24.06.2004	Request for preliminary examination filed International Preliminary Examining Authority: JP
	14.07.2005	Amendment by applicant (claims and/or description)
	14.07.2005	Examination requested [2005/43]
	20.09.2006	Despatch of a communication from the examining division (Time limit: M04)
	19.12.2006	Reply to a communication from the examining division
	14.07.2008	Communication of intention to grant the patent
	19.11.2008	Fee for grant paid
	19.11.2008	Fee for publishing/printing paid
Opposition(s)	15.10.2009	No opposition filed within time limit [2009/52]
Fees paid	Renewal fee
	23.01.2006	Renewal fee patent year 03
	25.01.2007	Renewal fee patent year 04
	23.01.2008	Renewal fee patent year 05
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	CY	14.01.2009
	EE	14.01.2009
	SI	14.01.2009
	LU	30.01.2009
	MC	31.01.2009
	BG	14.04.2009
	[2011/45]
Former [2011/21]	EE	14.01.2009
	SI	14.01.2009
	LU	30.01.2009
	MC	31.01.2009
	BG	14.04.2009
Former [2010/09]	EE	14.01.2009
	SI	14.01.2009
	MC	31.01.2009
	BG	14.04.2009
Former [2009/50]	EE	14.01.2009
	SI	14.01.2009
	MC	31.01.2009
Former [2009/41]	SI	14.01.2009
	MC	31.01.2009
Former [2009/36]	SI	14.01.2009
Documents cited:	Search	[PA]WO03013482 (STRAKAN GROUP LTD [GB], et al) [PA] 1-14 * claim 15 *;
		[E]EP1413294 (YAMANOUCHI PHARMA CO LTD [JP]) [E] 1-14* paragraphs [0021] , [0035]; claim 1 *
	International search	[Y]US4067974 (SASMOR ERNEST J);
		[Y]EP0274845 (BOOTS CO PLC [GB]);
		[Y]JPH0565226 (TAISHO PHARMA CO LTD, et al);
		[X]WO9917755 (GLAXO GROUP LTD [GB], et al);
		[Y]EP1205190 (YAMANOUCHI PHARMA CO LTD [JP]);
		[Y]US2002150624 (WATANABE SHUNSUKE [JP], et al);
		[Y] - YAKUJI NIPPO LTD, JAPAN PHARMACEUTICAL EXCIPIENTS COUNCIL, IYAKUHIN TENKABUTSU JITEN, (19940114), pages 2 - 3, 18, 39, 65, 113, 117, XP002904480
		[A] - MASAKI KATSUHIRO ET AL., "5-HT3 juyotai kikkogata seitozai 'nazea OD jyo 0.1mg' no butsuri kagakuteki seishitsu oyobi anteisei", ANTIBIOTICS & CHEMOTHERAPY, (1998), vol. 14, no. 3, pages 2004 - 2008, XP002904481
		[A] - KUWABARA TOSHIYUKI ET AL., "Regulation of 60kDa heat shock protein expression by systemic stress and 5-hydroxytryptamine in rat colonic mucosa", JOURNAL OF GASTROENTEROLOGY, (1994), vol. 29, no. 26, pages 721 - 726, XP002904482
		[A] - KISHIBAYASHI NOBUYUKI ET AL., "5-HT3 receptor antagonists.,3 quinoine derivatives which may be effective in the therapy of irritable bowel syndrome", JOURNAL OF MEDICINAL CHEMISTRY, (1993), vol. 36, no. 22, pages 3286 - 3292, XP002158321 DOI: http://dx.doi.org/10.1021/jm00074a009

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p